Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Absolute Bioavailability of Cenerimod in Healthy Male Participants
NCT07301723Phase 1Completed
- Sponsor
- Viatris
- Start
- Dec 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cenerimod, sponsored by Viatris. Primary endpoint: Absolute bioavailability. Started Dec 2025; status: completed.
02
Drugs
cenerimod
Beyond the preview
Go deeper on NCT07301723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07301723.